NO153725C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-(nafthylmethyl)-piperidin-derivater. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-(nafthylmethyl)-piperidin-derivater.Info
- Publication number
- NO153725C NO153725C NO800338A NO800338A NO153725C NO 153725 C NO153725 C NO 153725C NO 800338 A NO800338 A NO 800338A NO 800338 A NO800338 A NO 800338A NO 153725 C NO153725 C NO 153725C
- Authority
- NO
- Norway
- Prior art keywords
- naphthylmethyl
- preparation
- therapeutically active
- piperidine derivatives
- active new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/010,555 US4246268A (en) | 1979-02-09 | 1979-02-09 | Neuroleptic-4-(naphthylmethyl)piperidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO800338L NO800338L (no) | 1980-08-11 |
| NO153725B NO153725B (no) | 1986-02-03 |
| NO153725C true NO153725C (no) | 1986-05-14 |
Family
ID=21746302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO800338A NO153725C (no) | 1979-02-09 | 1980-02-08 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-(nafthylmethyl)-piperidin-derivater. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4246268A (ru) |
| JP (1) | JPS55105665A (ru) |
| AT (1) | AT374458B (ru) |
| AU (1) | AU526777B2 (ru) |
| BE (1) | BE881624A (ru) |
| CA (1) | CA1120036A (ru) |
| CH (1) | CH643542A5 (ru) |
| DE (1) | DE3002292A1 (ru) |
| DK (1) | DK152669C (ru) |
| ES (1) | ES486824A1 (ru) |
| FR (1) | FR2448531A1 (ru) |
| GB (1) | GB2041918B (ru) |
| HK (1) | HK96887A (ru) |
| IE (1) | IE48485B1 (ru) |
| IL (1) | IL58687A (ru) |
| IT (1) | IT1120639B (ru) |
| NL (1) | NL190193C (ru) |
| NO (1) | NO153725C (ru) |
| NZ (1) | NZ191709A (ru) |
| PH (1) | PH16648A (ru) |
| SE (1) | SE448725B (ru) |
| ZA (1) | ZA795131B (ru) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443462A (en) * | 1979-08-06 | 1984-04-17 | Merrell Dow Pharmaceuticals Inc. | Antipsychotic 4-(naphthalenyloxy)piperidine derivatives |
| FR2484415A1 (fr) * | 1980-06-13 | 1981-12-18 | Pharmindustrie | Nouveaux derives de l'indene, procedes pour leur preparation, et leur utilisation comme medicaments |
| FR2560873B1 (fr) * | 1984-03-09 | 1986-09-26 | Rhone Poulenc Sante | Medicaments a base de derives de la piperidine, nouveaux derives de la piperidine et leurs procedes de preparation |
| WO1987002359A1 (en) * | 1985-10-14 | 1987-04-23 | Maggioni-Winthrop S.P.A. | Dihydrobenzothiophene and thiochromane aminoalcohols |
| US4757079A (en) * | 1986-06-24 | 1988-07-12 | Dynamac Corporaton | Anti-hypertensive piperidine compounds |
| KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
| JP2573195B2 (ja) * | 1986-09-30 | 1997-01-22 | エーザイ株式会社 | 環状アミン誘導体 |
| US5523307A (en) * | 1987-11-27 | 1996-06-04 | Eisai Co., Ltd. | Cyclic amine and pharmacological composition |
| US5196439A (en) * | 1987-11-27 | 1993-03-23 | Eisai Co., Ltd. | Piperidine compounds useful to treat cerebrovascular diseases |
| US4921863A (en) * | 1988-02-17 | 1990-05-01 | Eisai Co., Ltd. | Cyclic amine derivatives |
| WO1990006303A1 (en) * | 1988-12-02 | 1990-06-14 | Pfizer Inc. | Arylpiperidine derivatives |
| US5077035A (en) * | 1990-05-14 | 1991-12-31 | The University Of Michigan | Radioiodinated benzovesamicol analogs for cholinergic nerve mapping |
| FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
| FR2664592B1 (fr) * | 1990-07-10 | 1994-09-02 | Adir | Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| EP0661266A1 (en) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituted cyclic amine compounds as 5HT2 antagonists |
| US6303627B1 (en) * | 1998-06-19 | 2001-10-16 | Eli Lilly And Company | Inhibitors of serotonin reuptake |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR86403E (fr) * | 1959-05-01 | 1966-02-04 | May & Baker Ltd | Nouveaux dérivés de la phényl-4 pipéridine et leur préparation |
| GB925429A (en) * | 1960-04-01 | 1963-05-08 | Irwin Neisler & Co | Indole derivatives |
| US3453283A (en) * | 1965-12-30 | 1969-07-01 | Abbott Lab | Novel 6-substituted-1-(piperidyl-alkyl)-1,2,3,4-tetrahydronaphthalenes |
| US3576810A (en) * | 1968-06-20 | 1971-04-27 | Robins Co Inc A H | 1-substituted-3-(-4)-aroylpiperidines |
| ZA717147B (en) * | 1970-11-27 | 1972-07-26 | Richardson Merrell Inc | 4-(4-(alpha-hydroxybenzyl)piperidino)-4'-fluorobutyrophenone derivatives |
| BE791088A (fr) * | 1971-11-09 | 1973-03-01 | Richardson Merrell Inc | Nouveaux derives d'aryl (piperidyl-4) cetone, utiles notamment comme analgesiques et anticoagulants, et leur procede de preparation |
| BE794333A (fr) * | 1972-01-20 | 1973-07-19 | Wyeth John & Brother Ltd | Composes heterocycliques azotes therapeutiques |
| US3806526A (en) * | 1972-01-28 | 1974-04-23 | Richardson Merrell Inc | 1-aroylalkyl-4-diphenylmethyl piperidines |
| US3888867A (en) * | 1972-05-03 | 1975-06-10 | Richardson Merrell Inc | 4-(4-(alpha-hydroxybenzyl)piperidino)4'-fluorobutyrophenone derivatives |
| US4101662A (en) * | 1973-05-03 | 1978-07-18 | A. H. Robins Company, Incorporated | Method for inhibiting emesis and compositions therefor |
| SE7409245L (ru) * | 1973-07-19 | 1975-01-20 | Robins Co Inc A H | |
| US3956296A (en) * | 1974-12-11 | 1976-05-11 | A. H. Robins Company, Incorporated | 1-Substituted-4-benzylpiperidines |
| DE2718405A1 (de) * | 1977-04-26 | 1978-11-02 | Boehringer Sohn Ingelheim | Neue n- eckige klammer auf 1-(3-benzoylpropyl)-4-piperidyl eckige klammer zu -sulfonsaeureamide und verfahren zu deren herstellung |
-
1979
- 1979-02-09 US US06/010,555 patent/US4246268A/en not_active Expired - Lifetime
- 1979-09-27 ZA ZA00795131A patent/ZA795131B/xx unknown
- 1979-09-28 IE IE1851/79A patent/IE48485B1/en not_active IP Right Cessation
- 1979-10-01 NZ NZ191709A patent/NZ191709A/xx unknown
- 1979-10-09 AU AU51610/79A patent/AU526777B2/en not_active Ceased
- 1979-10-10 GB GB7935255A patent/GB2041918B/en not_active Expired
- 1979-10-18 NL NLAANVRAGE7907686,A patent/NL190193C/xx not_active IP Right Cessation
- 1979-11-12 IL IL58687A patent/IL58687A/xx unknown
- 1979-11-23 CA CA000340542A patent/CA1120036A/en not_active Expired
- 1979-11-27 IT IT50921/79A patent/IT1120639B/it active
- 1979-12-12 ES ES486824A patent/ES486824A1/es not_active Expired
-
1980
- 1980-01-23 DE DE19803002292 patent/DE3002292A1/de active Granted
- 1980-01-25 PH PH23553A patent/PH16648A/en unknown
- 1980-01-30 JP JP887380A patent/JPS55105665A/ja active Granted
- 1980-02-01 AT AT0054880A patent/AT374458B/de not_active IP Right Cessation
- 1980-02-05 SE SE8000920A patent/SE448725B/sv not_active IP Right Cessation
- 1980-02-07 FR FR8002688A patent/FR2448531A1/fr active Granted
- 1980-02-08 DK DK055980A patent/DK152669C/da not_active IP Right Cessation
- 1980-02-08 NO NO800338A patent/NO153725C/no unknown
- 1980-02-08 CH CH106180A patent/CH643542A5/de not_active IP Right Cessation
- 1980-02-08 BE BE0/199324A patent/BE881624A/fr not_active IP Right Cessation
-
1987
- 1987-12-17 HK HK968/87A patent/HK96887A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO151085C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater | |
| NO153136C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater. | |
| NO152841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner. | |
| NO154919C (no) | Analogifremgangsmaate ved fremstilling av nye kinazolinderivater. | |
| NO152217C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 3-(1-imidazolylalkyl)indoler | |
| NO154964C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive piperidinderivater. | |
| NO152048C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 5h-2,3-benzodiazepinderivater | |
| NO149174C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme tiazinderivater | |
| NO147148C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater | |
| NO153725C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-(nafthylmethyl)-piperidin-derivater. | |
| NO154883C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-acylaminomethyl-1,4-benzodiazepiner. | |
| NO149733C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin | |
| NO154426C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater. | |
| NO148642C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater | |
| NO146392C (no) | Analogifremgangsmaate ved fremstilling av nye analgesisk aktive n-acetyl-para-aminofenyl-n`-acetyl-aminoalkansyreester-derivater | |
| NO150884C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater | |
| NO152654C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre | |
| NO145791C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater | |
| NO148926C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater | |
| NO155137C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 2-(4-piperidyl)-1-(4-kinolyl)-etanon. | |
| NO145618C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive spiro-(1,3-dioxolan-4,3`-kinuclidin-forbindelser | |
| NO142625C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater | |
| NO154920C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner. | |
| NO147150C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner. | |
| NO154396C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater. |